Evidence map›Paper›PMID 27941966›Full record

ArticlePLoS neglected tropical diseases2016

Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis.

Isabel M Vincent, Rónán Daly, Bertrand Courtioux, Amy M Cattanach, Sylvain Biéler, Joseph M Ndung'u, Sylvie Bisser, Michael P Barrett

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03112655 (Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03112655 nacompletednot on this mapstarted 2017, after this paper: background citation

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early Test-of-cure

TypeinterventionalSponsorInstitut de Recherche pour le DeveloppementRan2017 to 2021Enrolled88ConditionsAfrican Trypanosomiasis, African, Trypanosomiasis, West, Sleeping SicknessArmsRNA and neopterin detection
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The intersection of hostMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Cell-cell communication in African trypanosomes.Microbiology (Reading, England) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Sleeping Sickness: A Cause of False Positive HIV Rapid Diagnostic Tests].Medecine tropicale et sante internationale · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Generation of neuroinflammation in human African trypanosomiasis.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Isabel M VincentWellcome Trust Centre of Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Rónán DalyGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Bertrand CourtiouxINSERM U1094, Tropical Neuroepidemiology, Limoges, France; Université de Limoges, Institute of Neuroepidemiology and Tropical Neurology, Limoges, France.
Amy M CattanachGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Sylvain BiélerFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Joseph M Ndung'uFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Sylvie BisserINSERM U1094, Tropical Neuroepidemiology, Limoges, France; Université de Limoges, Institute of Neuroepidemiology and Tropical Neurology, Limoges, France.
Michael P BarrettWellcome Trust Centre of Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
FIND · CHInserm · FRUniversity of Glasgow · GBWellcome Centre for Molecular Parasitology · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I004599/1Medical Research Council MR/L018853/1Wellcome TrustWellcome Trust 104111/Z/14/ZWellcome Trust 105614/Z/14/Z
6 · The paper itself

Abstract

Treatment for human African trypanosomiasis is dependent on the species of trypanosome causing the disease and the stage of the disease (stage 1 defined by parasites being present in blood and lymphatics whilst for stage 2, parasites are found beyond the blood-brain barrier in the cerebrospinal fluid (CSF)). Currently, staging relies upon detecting the very low number of parasites or elevated white blood cell numbers in CSF. Improved staging is desirable, as is the elimination of the need for lumbar puncture. Here we use metabolomics to probe samples of CSF, plasma and urine from 40 Angolan patients infected with Trypanosoma brucei gambiense, at different disease stages. Urine samples provided no robust markers indicative of infection or stage of infection due to inherent variability in urine concentrations. Biomarkers in CSF were able to distinguish patients at stage 1 or advanced stage 2 with absolute specificity. Eleven metabolites clearly distinguished the stage in most patients and two of these (neopterin and 5-hydroxytryptophan) showed 100% specificity and sensitivity between our stage 1 and advanced stage 2 samples. Neopterin is an inflammatory biomarker previously shown in CSF of stage 2 but not stage 1 patients. 5-hydroxytryptophan is an important metabolite in the serotonin synthetic pathway, the key pathway in determining somnolence, thus offering a possible link to the eponymous symptoms of "sleeping sickness". Plasma also yielded several biomarkers clearly indicative of the presence (87% sensitivity and 95% specificity) and stage of disease (92% sensitivity and 81% specificity). A logistic regression model including these metabolites showed clear separation of patients being either at stage 1 or advanced stage 2 or indeed diseased (both stages) versus control.

Indexed as

5-HydroxytryptophanAdolescentAdultBiomarkersBlood-Brain BarrierFemaleHumansMaleMetabolomicsNeopterinRegression AnalysisSensitivity and SpecificityTrypanosoma brucei gambienseTrypanosomiasis, AfricanYoung Adult5-HydroxytryptophanBiomarkersNeopterin

Identifiers

PMID27941966
PMCPMC5152828
OpenAlexW2566871301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.